Evidence map›Paper›PMID 41628841›Full record

ArticleExperimental gerontology2026

Uncovering treatment effect heterogeneity in pragmatic gerontology trials.

Changjun Li, Heather Allore, Michael O Harhay, Fan Li, Guangyu Tong

Abstract read
In one paragraph

Article in Experimental gerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Changjun LiDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA; Cardiovascular Medicine Analytics Center, Yale School of Medicine, New Haven, CT, USA; Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT, USA.
Heather AlloreDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA; Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Michael O HarhayPalliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Clinical Trials Innovation, Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Fan LiDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA; Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Guangyu TongDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA; Cardiovascular Medicine Analytics Center, Yale School of Medicine, New Haven, CT, USA; Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. Electronic address: guangyu.tong@yale.edu.

Funding

Training Core (I)U54AG063546 · NIA · BROWN UNIVERSITY · PI Alexia Mary Torke · 2019 to 2026
$125.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Lauren Ferrante · 2002 to 2026
$37.9M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
Advancing the design, analysis, and interpretation of acute respiratory distress syndrome trials using modern statistical toolsR01HL168202 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Michael Oscar Harhay, Fan Li · 2023 to 2026
$2.9M
New win methods for addressing multiple and composite outcomes in cluster-randomized trialsR01HL178513 · NHLBI · YALE UNIVERSITY · PI Fan Li · 2025 to 2026
$1.4M
NHLBI NIH HHS R01 HL168202NHLBI NIH HHS R01 HL178513NIA NIH HHS P30 AG021342NIA NIH HHS P30 AG066508NIA NIH HHS U54 AG063546
6 · The paper itself

Abstract

Detecting heterogeneity in treatment response enriches the interpretation of gerontologic trials. In aging research, estimating the intervention's effect on clinically meaningful outcomes poses analytical challenges when outcomes are truncated by death. For example, in the Whole Systems Demonstrator trial, a large cluster-randomized study evaluating telecare among older adults, the overall effect of the intervention on quality of life was found to be null. However, this marginal intervention estimate obscures potential heterogeneity of individuals responding to the intervention, particularly among those who survive to the end of follow-up. To explore this heterogeneity, we adopt a causal framework grounded in principal stratification, targeting the Survivor Average Causal Effect (SACE)-the treatment effect among "always-survivors," or those who would survive regardless of treatment assignment. We extend this framework using Bayesian Additive Regression Trees (BART), a nonparametric machine learning method, to flexibly model both latent principal strata and stratum-specific potential outcomes. This enables the estimation of the Conditional SACE (CSACE), allowing us to uncover variation in treatment effects across subgroups defined by baseline characteristics. Our analysis reveals that despite the null average effect, some subgroups experience distinct quality of life benefits (or lack thereof) from telecare, highlighting opportunities for more personalized intervention strategies. This study demonstrates how embedding machine learning methods, such as BART, within a principled causal inference framework can offer deeper insights into trial data with complex features including truncation by death and clustering-key considerations in analyzing pragmatic gerontology trials.

Indexed as

GeriatricsPragmatic Clinical Trials as TopicAgedBayes TheoremFemaleHumansMachine LearningQuality of LifeRandomized Controlled Trials as TopicTreatment Effect HeterogeneityBayesian inferenceCluster randomized trialGerontology trialsMachine learningPragmatic trialsPrincipal stratificationSurvivor average causal effectWhole Systems Demonstrator Telecare Questionnaire Study

Identifiers

PMID41628841
PMCPMC13054727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.